Kingmed Medical's newly registered "Kingmed Group Qualification Certificate Management Platform V1.0" project software copyright

NightAirdropper · 2026-03-08T01:25:12+00:00

Kingmed Medical's new registration of the "Kingmed Group Qualification Certificate Management Platform V1.0" software copyright, and this year the number of newly registered copyrights decreased to 20. In the first half of 2025, the company's R&D investment was 161 million yuan, a year-on-year decrease of 18.32%. The company has invested in 58 enterprises externally, participated in 29 bidding processes, and possesses extensive trademark, patent, and copyright information.

NightAirdropper

2026-03-08 01:25:12

Abstract generation in progress

Securities Star News: Recently, Jin Yu Medical (603882) registered a new software copyright for the project “Jin Yu Group Qualification Certificate Management Platform V1.0.” Since the beginning of this year, Jin Yu Medical has registered 20 new software copyrights, a decrease of 28.57% compared to the same period last year. According to the company’s 2025 mid-year financial report, in the first half of 2025, the company invested 161 million yuan in research and development, a decrease of 18.32% year-on-year.

According to data analysis from Tianyancha, Guangzhou Jin Yu Medical Testing Group Co., Ltd. has invested in 58 companies, participated in 29 bidding projects; in terms of property clues, there are 766 trademark information records, 220 patent records, and 188 copyright records; additionally, the company holds 57 administrative licenses.

Data source: Tianyancha APP

The above content is compiled from publicly available information by Securities Star and generated by AI algorithms (Network Information Calculation Backup No. 310104345710301240019). It does not constitute investment advice.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.